News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca LP (AZN) Discontinues LEXXEL (enalapril maleate-felodipine ER) Tablets



12/28/2007 9:01:27 AM

San Francisco, Calif. – AstraZeneca announces it has no further plans to manufacture or distribute LEXXEL (enalapril maleate-felodipine ER) Tablets after July 31, 2008.

LEXXEL is indicated for the treatment of hypertension. For more information, please contact AstraZeneca LP Contact Corporate Information Center at 800-236-9933.

To view a complete list of discontinued drugs from the FDA, visit: http://www.fda.gov/cder/drug/shortages/default.htm#disc

Contact Suvarna Bhatt at sbhatt@biospace.com.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES